The affirmation is a result of several factors, including Erlanger’s strong revenue growth, improved market share and solid investments in new facilities and clinical programs. Moody’s also acknowledged the health system’s recent IT conversion that resulted in higher expenses in the first half of fiscal year 2018.
The outlook is positive, reflecting Moody’s expectation that Erlanger will see further revenue growth as the added costs of the IT installation decline.
More articles on healthcare finance:
Good Samaritan Hospital receives $21M gift from Berkshire Hathaway chairman
Moody’s: Nonprofit hospital rating downgrades rose sharply in 2017
Disney pledges $100M to enhance the patient experience at children’s hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
